At a glance
ClinicalIndex Comparison RecordN/ACompleted· 70 enrolled
Drug / intervention
Roche AMPLICOR CT/NG +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Cepheid Xpert CT/NG For Management of STI in the ED: Immediate V. Delayed Test Results
In Brief
A clinical study evaluating Roche AMPLICOR CT/NG and Cepheid Xpert CT/NG Test for Reproductive Tract Infections. Completed, enrolled 70 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if immediate availability of GeneXpert® CT/NG test results reduces the overtreatment rate for ED patients with suspected gonorrhea or chlamydia and to assess changes in clinician management decisions with real-time test results.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsReproductive Tract Infections
CountriesUnited States
CollaboratorsCepheid
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartOct 2013
First PostedNov 2013
Primary CompletionMar 2015
TodayJul 2026
First PostedNov 20, 2013
Enrollment StartOct 1, 2013
Primary CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 12.6 years ago
Interventions
Roche AMPLICOR CT/NGdevice
Cepheid Xpert CT/NG Testdevice